Cognitive-behavioural therapy for the management of inflammatory bowel disease-fatigue: a feasibility randomised controlled trial

Table 4 Means, standard deviations, change scores and effect sizes of participants who completed baseline and 3 months’ follow-up primary and secondary outcome measures

Outcome	Group	Baseline		3 months’ follow-up			Change scores			Between group effect sizes (CI)
		Mean	SD	Mean	SD	N	Mean	SD	MD (CI)
IBDF-1	Group 1	11.12	3.56	7.00	3.74	8	− 4.12	4.91	− 2.94 (− 7.21, 1.32)	0.84 (− 0.5, 1.82)
IBDF-1	Group 2	10.63	4.25	9.45	4.87	11	− 1.18	2.28	− 2.94 (− 7.21, 1.32)	0.84 (− 0.5, 1.82)
IBDF-2	Group 1	53.25	31.67	23.00	16.38	8	− 30.25	23.90	− 26.14 (− 29.30, − 2.98)	1.20 (0.13, 2.27)
IBDF-2	Group 2	51.44	33.24	47.33	31.11	9	− 4.11	20.08	− 26.14 (− 29.30, − 2.98)	1.20 (0.13, 2.27)
IBDQ	Group 1	90.80	15.08	97.50	11.20	10	6.70	11.09	2.70 (− 6.45, 11.85)	− 0.25 (− 1.21, 0.72)
IBDQ	Group 2	91.70	9.79	95.70	10.54	10	4.40	8.01	2.70 (− 6.45, 11.85)	− 0.25 (− 1.21, 0.72)

CI confidence interval, IBD-F Inflammatory Bowel Disease-Fatigue, IBDQ Inflammatory Bowel Disease Questionnaire MD mean difference, SD standard deviation

ISSN: 2055-5784